NDCAX | VASIX | NDCAX / VASIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 25 years | 30 years | - |
Gain YTD | 0.000 | 0.000 | - |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 282M | 4.01B | 7% |
Annual Yield % from dividends | 3.37 | 3.30 | 102% |
Returns for 1 year | 3.03 | 2.55 | 119% |
Returns for 3 years | -2.81 | -4.58 | 61% |
Returns for 5 years | 7.54 | 2.21 | 341% |
Returns for 10 years | 19.46 | 23.59 | 83% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BLNAX | 12.63 | N/A | N/A |
Meeder Balanced Adviser | |||
LRMAX | 23.07 | -0.04 | -0.17% |
Lord Abbett Dividend Growth F3 | |||
ABCRX | 20.87 | -0.10 | -0.48% |
American Beacon The London Co Inc Eq R6 | |||
AMAEX | 10.67 | -0.08 | -0.74% |
American Century Small Cap Dividend Inv | |||
MDNAF | 1.12 | -0.03 | -2.62% |
Medicenna Therapeutics Corp. |